from Global Health Program

A Year Out: Addressing International Impacts of the COVID-19 Pandemic

March 18, 2021

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

In his testimony before the U.S. House of Representatives Committee on Foreign Affairs, Thomas J. Bollyky provides an overview of current engagement of the United States and its allies in addressing the global inequities in vaccine distribution; the emerging circumstances that justify increased U.S. engagement in coronavirus vaccine diplomacy; and a proposal for a U.S.-led initiative to increase the capacity, transparency, and resilience of vaccine manufacturing in order to meet U.S. and global needs.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

Top Stories on CFR

United States

Temporary protected status has long been used as a humanitarian solution for migrants who are unable to return home safely, but efforts to end the program have reignited the debate around U.S. immigration policy.  

Afghanistan

Millions of Afghans are struggling to survive after crucial foreign aid was halted due to the Taliban’s takeover. Images from Afghanistan show a catastrophe in a country already traumatized by decades of war.

Russia

Russia has demanded security guarantees that U.S. and NATO officials cannot accept, but there could still be room for building a sustainable dialogue on European security.